Kainova Therapeutics

Montreal, Canada · Founded 2001 · Privately Held (backing)

Developer of medical therapeutics designed for the treatment of central nervous system (CNS) diseases and cancer. Kainova Therapeutics is based in Montreal, Canada and was founded in 2001. Its last reported valuation was $92 million in May 2022. It has raised $114 million.

Last reported valuation

$92.0M

Oct 2026

Priced at

—

Total raised

$113.9M

Last round

—

How much has Kainova Therapeutics raised?

$113.9Macross 0 recorded rounds

Free account

More of Kainova Therapeutics with a free account

·The complete investor list: 14 names
·Watch Kainova Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Kainova Therapeutics investors

14 investors are on record for Kainova Therapeutics, including Investissement Quebec, Omnes Capital, Turenne Groupe and Schroders Capital.

For fundraisers

Raising for a company like Kainova Therapeutics?

14 investors have backed Kainova Therapeutics.

See all 14 investors →

Frequently asked about Kainova Therapeutics

How much has Kainova Therapeutics raised?: Kainova Therapeutics has raised $113.9M in total across 0 recorded funding rounds.